Sign in
IMMG Stock Price, Chart, Stats & News
Immage Biotherapeutics Corp.
Save
Immage Biotherapeutics Corp. (IMMG) does not currently pay a dividend.
15,174
Market cap
–
Current P/E
–
Forward P/E
IMMG chart
1M
3M
1Y
5Y
Loading chart...
About
Financial Services
Sector
Financial - Conglomerates
Industry
Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherapeutics Corp. in June 2015.
Similar securities
Based on sector and market capitalization
Report issue